Detalles de la búsqueda
1.
Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b(+) HLA-A24(+) patients.
Hepatol Res
; 37(3): 186-95, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17362301
2.
Antitumor effects of systemic and local immunization with a CTL-directed peptide in combination with a local injection of OK-432.
Clin Cancer Res
; 12(4): 1325-32, 2006 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16489090
3.
Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report.
Hepatol Res
; 36(3): 229-36, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16949861
4.
Identification of hepatitis C virus 1b-derived peptides recognized by both cellular and humoral immune systems in HCV1b(+) HLA-A24(+) patients.
Hepatol Res
; 32(4): 227-34, 2005 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-16095964
5.
New type of natural antibodies reactive to cytotoxic T lymphocyte-directed cancer vaccine peptides.
Immunobiology
; 209(3): 245-53, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15518336
6.
Predictive factors associated with the progression to hepatic failure caused by lamivudine-resistant HBV.
Dig Dis Sci
; 53(11): 2999-3006, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18618250
7.
Serum levels of IgG to the peptide of HCV1b core at positions 35-44 correlated with persistent infection, while levels of IgG to the peptide of NS5A at positions 2132-2140 correlated with better prognosis in HCV-infected patients.
Med Microbiol Immunol
; 196(3): 157-64, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17574493
8.
A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33.
Cancer Immunol Immunother
; 56(9): 1359-66, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17265020
9.
Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferon-based therapy.
Vaccine
; 25(42): 7429-35, 2007 Oct 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-17845828
10.
Nonmutated self-antigen-derived cancer vaccine peptides elicit an IgE-independent but mast cell-dependent immediate-type skin reaction without systemic anaphylaxis.
J Immunol
; 176(2): 857-63, 2006 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16393969
11.
New epitope peptides derived from hepatitis C virus (HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patients.
Microbiol Immunol
; 50(11): 857-65, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-17116980
12.
Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patients.
Cell Immunol
; 241(1): 38-46, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16963008
13.
New epitope peptides derived from parathyroid hormone-related protein which have the capacity to induce prostate cancer-reactive cytotoxic T lymphocytes in HLA-A2+ prostate cancer patients.
Prostate
; 62(3): 233-42, 2005 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15389794
14.
Antibody reactive to a hepatitis C virus (HCV)-derived peptide capable of inducing HLA-A2 restricted cytotoxic T lymphocytes is detectable in a majority of HCV-infected individuals without HLA-A2 restriction.
Microbiol Immunol
; 48(7): 507-17, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15272196
Resultados
1 -
14
de 14
1
Próxima >
>>